Scientific letter N°8

After a year of growth in 2012, ATLANCHIM PHARMA moved in 2013 into a new building corresponding to our specificities. Indeed, we left our offices in the Faculty of Medicine and we relocated ourselves in Saint-Herblain into a biotech environment.
This new premise represents more than 1200m² of laboratory in R&D (both chemistry and biology), commercial and administrative offices as well as animal facilities that fulfill the higher requirements of the applicable sanitary measure. In addition, we had the opportunity to bring together the research teams from ATLANCHIM PHARMA and ATLANTIC BONE SCREEN.
Consequently, ATLANCHIM PHARMA strengthened its production capacity and analytical services. Thanks to this new organization, we acquired new equipments such as UPLC-MS, HPLC semi-preparative … which enable us to respond efficiently to our customers.
On the other hand, attached to customers’ satisfaction and quality, ATLANCHIM PHARMA increases its staff with the arrival of our new Quality Manager in July 2013.
In this new edition of our scientific letter, you will appreciate the presentation of one of our Project Managers, Dr. Julien FARARD.
Finally, you will also be pleased to discover the scientific publication entitled « Amide Bond Formation beyond the Peptide Synthesis », written by our Scientific Director, Prof. Jacques LEBRETON.
The ATLANCHIM PHARMA team joins me in wishing you an enjoyable read !

Ronan LE BOT
Directeur/CEO